Among survivors treated by chemotherapy, the increased risk of cancer death became similar for ER-positive and ER-negative survivors for second breast cancer, thyroid cancer, and leukemia, but not for second lung cancer and lymphoma (Table 4). Here, ESR1 is linked to cancer.